瑞康医药 (002589)

Realcan Pharmaceutical Group Co.,Ltd.

ASZ

Tags

Special Purpose LoansArtificial Intelligence (AI)Elderly Care ConceptCold Chain LogisticsInnovative DrugsBlockchainPharmaceuticals and HealthcarePharmaceutical CommerceExoskeletonLow-Profit StocksWholesaleSmart HealthcareBelow Net Asset ValueMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 150471.05
  • Circulating A-Shares(W): 136559.15
  • Earnings Per Share(RMB): 0.0081
  • Net Assets Per Share(RMB): 3.5548
  • Operating Revenue(W RMB): 540653.36
  • Total Profit(W RMB): 454.50
  • Net Profit Attributable to Parent(W RMB): 1213.66
  • Net Profit Growth Rate(%): -68.73
  • Weighted Return on Equity(%): 0.2200
  • Operating Cash Flow Per Share(RMB): 0.0270
  • Undistributed Profit Per Share(RMB): 0.1689
  • Capital Reserve Per Share(RMB): 2.3148

2. Main Business

The main business covers:

  • Pharmaceutical and medical device distribution
  • In vitro diagnostics
  • Pharmaceutical logistics
  • Traditional Chinese medicine
  • Micro-ecological medicine

3. Company Basic Information

  • Company Name: Realcan Pharmaceutical Group Co., Ltd.
  • Listing Date: 2011-06-10
  • Industry: Medicine and Medical - Pharmaceutical Commerce (CSRC Industry: Wholesale)
  • Address: No. 326 Airport Road, Zhifu District, Yantai City, Shandong Province
  • Website: www.realcan.cn
  • Company Profile: The company was established by the overall change of Shandong Realcan Pharmaceutical Distribution Co., Ltd. On November 15, 2009, according to the resolution of the board of directors of Realcan Distribution and the "Sponsor Agreement", Realcan Distribution converted its audited net assets as of October 31, 2009 into shares and legally changed into a joint stock limited company. As of October 31, 2009, the audited book net assets of Realcan Distribution were 221.9311 million yuan, which was converted into 70 million shares at a conversion ratio of 1:0.3154, and the balance was included in capital reserve. The company was changed to Shandong Realcan Pharmaceutical Co., Ltd., with a registered capital of 70 million yuan after the change. On December 3, 2009, the Shandong Provincial Department of Commerce issued the "Approval on Changing Shandong Realcan Pharmaceutical Distribution Co., Ltd. to a Foreign-invested Joint Stock Limited Company" (Lu Shang Wai Zi Zi [2009] No. 390) approving the change. On December 15, 2009, the company obtained the "Business License" issued by the Shandong Provincial Administration for Industry and Commerce with registration number 370602228025440, and the registered capital was 70 million yuan.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Jingzhou Zhaoshang Huize Pharmaceutical Investment Partnership Enterprise (Limited Partnership) General Legal Person 7523.54 5.51
2 Great Wall Guorong Investment Management Co., Ltd. General Legal Person 2684.57 1.97
3 Shanghai Aidong Industrial Co., Ltd. General Legal Person 1028.66 0.75
4 Qingdao Chengtou Chengjin Holding Group Co., Ltd. General Legal Person 810.00 0.59

5. Concept Sectors

  • Pension Concept
  • Smart Healthcare
  • Blockchain
  • Artificial Intelligence
  • Cold Chain Logistics
  • Innovative Drugs
  • Exoskeleton
  • Margin Trading & Securities Lending
  • Low-Profit Stock
  • Below Net Asset Value
  • Special Loan

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information